Skip to content

Exploring how to commercialise medical technology

At a recent Medical Technology Workshop, experts shared their perspectives on the challenges of bringing ideas to commercial and clinical fruition - exploring all aspects of medical technology development and commercialisation.

Experts from government, industry, health and education sectors spoke about the development, clinical validation and funding models needed to bring medical technologies to the clinic in order to improve health across the community.

Deputy Principal of the UNSW Medicine Cancer Theme and workshop convenor, A/Prof Phoebe Phillips explained,

“The best chance for commercialisation of your medical technology is starting with a clinical problem, strategically select the best interdisciplinary team, have an intellectual property plan, ensure there is a market for your technology and integrate a regulatory approval strategy throughout pipeline,” she said.

“I was motivated by the willingness of the MedTech industry and entrepreneurs to share their expertise and advice freely with academics.  I look forward to building these relationships to support academics and increase partnerships with industry to foster translation.”

Read the workshop program or watch the four workshop sessions for more tips:

·      SESSION 1: Project Development to Proof of Concept

·      SESSION 2: Product Development, Clinical Validation, and Market Entry

·      SESSION 3: Partnerships and Funding

·      SESSION 4: Case Studies

The workshop was sponsored by UNSW Medicine and two clinical academic groups (CAGs) from the Maridulu Budyari Gumal (SPHERE) network, the Triple I CAG and Cancer CAG. It was facilitated by Professor Joanne Tipper (co-director of Frontiers Technology CAG) from UTS.

Join Us

Maridulu Budyari Gumal, the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) has partnered with Join Us to save lives and improve the health of all Australians and we need your help!

On the Road to Smarter Stroke Care

“Using improved medications, like Tenecteplase, with telehealth and stroke-ready ambulances will mean more Australians will receive urgent pre-hospital care within the precious treatment window where we can really make a difference.” - Professor Mark Parsons

‘A World Turned Topsy Turvy’: Maridulu Budyari Gumal - SPHERE CCI&KT Platform Uses Art to Communicate COVID-19 Experiences

The 'Topsy Turvy' exhibition – created through a unique collaboration with SPHERE Council members and the SPHERE CCI&KT Strategic Platform –  uses art to document, share, and generate new insights into COVID-19 experiences.